BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35903294)

  • 21. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma.
    Xu L; Chang Y; An H; Zhu Y; Yang Y; Xu J
    Urol Oncol; 2015 Aug; 33(8):340.e1-8. PubMed ID: 26051357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
    Wang S; Jia M; He Z; Liu XS
    Oncogene; 2018 Jul; 37(29):3924-3936. PubMed ID: 29695832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
    Aydin AM; Singla N; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Westerman ME; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V; Krabbe LM
    World J Urol; 2019 Nov; 37(11):2419-2427. PubMed ID: 30759271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
    Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
    Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
    Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
    Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.
    Mori S; Takeuchi T; Ishii Y; Yugawa T; Kiyono T; Nishina H; Kukimoto I
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.
    Yates DR; Catto JW
    World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marital status independently predicts survival of patients with upper urinary tract urothelial carcinoma: A population-based study.
    Li K; Wang F; Wang J; Fan C; Sun J
    J Cancer Res Ther; 2021 Dec; 17(7):1709-1717. PubMed ID: 35381743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
    Wang Q; Zhang T; Wu J; Wen J; Tao D; Wan T; Zhu W
    BMC Urol; 2019 Apr; 19(1):24. PubMed ID: 30999871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.
    Li WM; Ke HL; Kuo YH; Lai HY; Chan TC; Hsing CH; Hsieh KL; Li WS; Chen TJ; Wei YC; Wu WJ; Huang SK; Li CF
    Oncology; 2022; 100(9):485-497. PubMed ID: 35817020
    [No Abstract]   [Full Text] [Related]  

  • 34. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.
    Xie J; Zhang XB; Wen J; Zhang YS; Li HZ
    Int Urol Nephrol; 2016 Apr; 48(4):481-7. PubMed ID: 26797856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma.
    Grahn A; Eisfeldt J; Malm C; Foroughi Asl H; Jaremko G; Tham E; Brehmer M
    BJU Int; 2022 Jul; 130(1):92-101. PubMed ID: 34375486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
    Soria F; Shariat SF; Lerner SP; Fritsche HM; Rink M; Kassouf W; Spiess PE; Lotan Y; Ye D; Fernández MI; Kikuchi E; Chade DC; Babjuk M; Grollman AP; Thalmann GN
    World J Urol; 2017 Mar; 35(3):379-387. PubMed ID: 27604375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
    van Doeveren T; van de Werken HJG; van Riet J; Aben KKH; van Leeuwen PJ; Zwarthoff EC; Boormans JL
    Urol Oncol; 2020 Jun; 38(6):590-598. PubMed ID: 32057596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.
    Nison L; Rouprêt M; Bozzini G; Ouzzane A; Audenet F; Pignot G; Ruffion A; Cornu JN; Hurel S; Valeri A; Roumiguie M; Polguer T; Hoarau N; Mérigot de Treigny O; Xylinas E; Matte A; Droupy S; Fais PO; Descazeaud A; Colin P;
    World J Urol; 2013 Feb; 31(1):69-76. PubMed ID: 23070533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.